Ignite Creation Date:
2025-12-24 @ 10:03 PM
Ignite Modification Date:
2026-01-03 @ 6:58 PM
Study NCT ID:
NCT03220035
Status:
COMPLETED
Last Update Posted:
2025-01-27
First Post:
2017-07-17
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Vemurafenib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With BRAF V600 Mutations (A Pediatric MATCH Treatment Trial)
Sponsor:
National Cancer Institute (NCI)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-11-08
Start Date Type:
ACTUAL
Primary Completion Date:
2022-06-30
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-12-31
Completion Date Type:
ACTUAL
First Submit Date:
2017-07-17
First Submit QC Date:
None
Study First Post Date:
2017-07-18
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2023-05-10
Results First Submit QC Date:
None
Results First Post Date:
2023-09-13
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-01-04
Last Update Post Date:
2025-01-27
Last Update Post Date Type:
ACTUAL